بررسی ارزش پروگنوزتیک و پاتوکلینیکی TIGIT در بیماران مبتلا به سرطان های توپر: مطالعه فراتحلیلی و نظام مند

مجریان: بهزاد برادران

خلاصه روش اجرا: The current study will be conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement (1). The Web of Science, Embase, PubMed, and Scopus databases will be systematically searched to obtain the relevant records published. For this purpose, the aforementioned databases will be systematically searched with the following keywords: ("tumor" OR "tumour" OR "malignancy" OR "neoplasm" OR "neoplasia" OR "malignant" OR "carcinoma" OR "cancerous" OR "tumoral" OR "tumoural" OR "neoplastic") and ("T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain" OR "T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain" OR "T Cell Immunoreceptor With Ig and ITIM Domains" OR "T cell immunoglobulin and ITIM domain" OR "T-Cell Immunoreceptor With Ig and ITIM Domains" OR "T-cell immunoglobulin and ITIM domain" OR "V-Set and Transmembrane Domain-Containing Protein 3" OR "V-Set and Transmembrane Domain Containing 3" OR "V-Set and Immunoglobulin Domain-Containing Protein 9" OR "V-Set and Immunoglobulin Domain Containing 9" OR "VSIG9" OR "VSTM3" OR "WUCAM" OR "TIGIT").